NANHU PHARMA

中文简体 | ENGLISH

ABOUT US

Introduction

Zhejiang Holley Nanhu Pharmaceutical Co., Ltd. (Nanhu Pharma)  is a subsidiary company of Holley Group. It integrates the business of manufacturing, research and development, sales and marketing of finished pharmaceutical products. Established in 1969, the company locates in Jiaxing City, with both one hour drive between Shanghai and Hangzhou. The plant occupies a land of 30,000m2, within it the architectural area is 14,000m2.

Nanhu Pharma of one of the major manufacturers of artemisinin based antimalarials in China. The first Duo-Cotecxin (dihydroartemisinin/piperaquine phosphate fixed dose) was manufactured here in 2005. Before that, Cotecxin (dihydroartemisinin monotherapy) was also manufactured at Nanhu.

Besides antimalarials, antibiotics and gastrointestinal medicines are manufactured here. They are amoxicillin capsule, amoxicillin/clavulanate potassium for suspension, cephalexin/cefradine/cefixime capsules, cefaclor dispersible tablets, omeprazole enteric-coated tablets, guacetisal for suspension.

The company has four workshops of oral products (ordinary multi-product and oral solution product, cephalosporin-product, penicillin-product) and ten modern production lines. The cephalosporin-product and penicillin-product workshops are within two separate buildings. All production lines are GMP certified by SFDA (Chinese regulatory authority). The ordinary multi-product production line was inspected twice and accepted as WHO GMP compliant in 2006 and 2012.